Highest-materiality recent filing
Milestone Scientific reprices CEO & SVP options and proposes PRSU plan with up to 17.2M shares
CEO Eric Hines and SVP Jason Papes surrender options at $0.46-$0.50 for new options at $0.31 exercise price.
Milestone Scientific dismisses auditor CBIZ; engages Grassi & Co. effective May 15, 2026
CBIZ CPAs' 2025 audit report included a going concern explanatory paragraph about substantial doubt.
Milestone Scientific closes $2.15M private placement of units at $0.27/unit
Issued 7,962,963 units, each consisting of one common share and one warrant (exercise $0.3375, 3-yr term).
Milestone Scientific amends MOU with Innovest/BP4, extends lock-up deadline to April 17, 2026
Amendment extends deadline for BP4 lock-up agreements to April 17, 2026, with automatic extension to May 1 if a capital raise is underway.
Milestone Scientific increases authorized common shares from 100M to 125M
Certificate of Amendment filed with Delaware Secretary of State on March 10, 2026, effective upon filing.
MLSS enters amended MoU locking up ~8.9M BP4 shares for 12 months post-$2.5M qualified offering
BP4 (controlled by Innovest) agrees to lock up ~8.9M shares of MLSS for 12 months after a Qualified Offering raising at least $2.5M.
Milestone Scientific enters lock-up agreement with 11.31% shareholder BP4 after $2.5M offering
BP4 S.r.l., holder of 11.31% of MLSS common stock, agrees to 12-month lock-up after $2.5M offering.
All six incumbent directors re-elected with average 92.84% votes for; Benedicta Casamento got 85.92%.
Director Leonard A. Osser resigns from board, remains employed and consulting
Leonard A. Osser resigned as director effective November 7, 2025.
Milestone Scientific receives NYSE American delisting notice for non-compliance
Received NYSE American letter on Oct 8, 2025, citing non-compliance with Sections 1003(a)(ii) and (iii) of the Company Guide.
Milestone Scientific appoints Eric Hines as CEO; compensation includes options for 2M shares
Eric Hines named President and CEO effective July 31, 2025; also appointed to the Board.
Milestone Scientific appoints Shanth Thiyagalingam as independent director
Appointed on May 14, 2025 as an independent director; fills Board vacancy.
Milestone Scientific replaces auditor Marcum LLP with CBIZ CPAs P.C.
Marcum LLP resigned effective April 22, 2025; CBIZ CPAs P.C. engaged for FY ending Dec 31, 2025.
Director Giandomenico Trombetta resigns from Milestone Scientific board
Giandomenico Trombetta resigned as director effective January 12, 2025, citing personal reasons and immediate matters.
Milestone Scientific finalizes consulting agreement with ex-CEO Arjan Haverhals
Consulting agreement with RH Consulting LLC effective Jan 1, 2025, for indefinite term.
CEO Arjan Haverhals retires as officer on Dec 31, 2024; remains director and consultant through family company.
Milestone Scientific posts investor presentation on Sep 27; details not in filing
Investor presentation made available on company website on September 27, 2024.
Milestone Scientific annual meeting elects all directors, ratifies auditors
All seven incumbent directors elected with at least 30 million shares for each; broker non-votes 20.4 million on each.
Milestone Scientific nets $1.98M from selling NOLs and R&D credits to Comcast
Received net $1,983,095 from Comcast Corporation on April 8, 2024 for unused NOLs and R&D tax credits.
On May 14, 2025, the Board of Directors of Milestone Scientific Inc. (the “Company”) unanimously by the directors in attendance appointed Shanth Thiyagalingam as an independent director of the Company.
On January 12, 2025, Mr. Giandomenico Trombetta, a director of Milestone Scientific Inc. (the “Company”), advised the Chairman of the Board that he is resigning, effective immediately, as a director.
Mr. Neal Goldman, the Chairman of the Board of Directors of the Company, has been appointed the Interim Chief Executive Officer, effective on Mr. Haverhals retirement.
On November 8, 2024, Mr. Arjan Haverhals, the Chief Executive Officer of Milestone Scientific Inc. (the “Company”), advised the Chairman of the Board that he intends to retire as an officer from the Company upon the expiration of, and not seek the renewal of, his employment agreement, on December 31, 2024.
Max materiality 0.75 · Median 0.50 · Most common event other_material